This study is for patients who had surgery for low-risk endometrial cancer, a type of cancer that affects the lining of the uterus. After surgery, the removed tissue is checked in a lab to see if more treatment is needed. This may include radiation or chemotherapy.
- This study lasts for 3 years, with follow-up visits every 6 months for the first 3 years, and annually afterward.
- Patients may need imaging tests like chest X-rays, CT scans, or MRIs during the study.
- No previous chemotherapy or radiation for the current cancer diagnosis is allowed for this study.
To be eligible, patients must have had surgery, be at least 18 years old, and able to complete study questionnaires. The study also requires that patients are available for treatment and follow-up visits. Participants must agree to return to their care facility for any side effects during the study.